Sophie Paczesny

Best Publications

• The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases

  Brad Griesenauer;Sophie Paczesny

  618
  Citations

• The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.

  Kenneth R. Cooke;Leo Luznik;Stefanie Sarantopoulos;Frances T. Hakim

  493
  Citations

• A biomarker panel for acute graft-versus-host disease

  Sophie Paczesny;Sophie Paczesny;Oleg I Krijanovski;Thomas M Braun;Sung Won Choi

  488
  Citations

• ST2 as a Marker for Risk of Therapy-Resistant Graft-versus-Host Disease and Death

  Mark T. Vander Lugt;Thomas M. Braun;Samir Hanash;Jerome Ritz

  436
  Citations

• Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease

  James L.M. Ferrara;Andrew C. Harris;Joel K. Greenson;Thomas M. Braun

  371
  Citations

• Dendritic cells: controllers of the immune system and a new promise for immunotherapy.

  Jacques Banchereau;Sophie Paczesny;Patrick Blanco;Lynda Bennett;Lynda Bennett

  321
  Citations

• Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway.

  Yin Ping Li;Sophie Paczesny;Sophie Paczesny;Evelyne Lauret;Sonia Poirault

  305
  Citations

• Elafin Is a Biomarker of Graft-Versus-Host Disease of the Skin

  Sophie Paczesny;Thomas M. Braun;John E. Levine;Jason Hogan

  285
  Citations

• Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease

  John E. Levine;Sophie Paczesny;Shin Mineishi;Thomas Braun

  229
  Citations

• Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study.

  John E. Levine;Brent R. Logan;Juan Wu;Amin M. Alousi

  228
  Citations

• New perspectives on the biology of acute GVHD

  S Paczesny;D Hanauer;Y Sun;P Reddy

  210
  Citations

• Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival.

  Sung W. Choi;Carrie L. Kitko;Thomas Braun;Sophie Paczesny

  189
  Citations

• Frequency of CD4+CD25hiFOXP3+ Regulatory T Cells Has Diagnostic and Prognostic Value as a Biomarker for Acute Graft-versus-Host-Disease

  John M. Magenau;Xuemei Qin;Xuemei Qin;Isao Tawara;Clare E. Rogers

  187
  Citations

• National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III: The 2014 biomarker working group report

  Sophie Paczesny;Frances T. Hakim;Joseph Pidala;Kenneth R. Cooke

  174
  Citations

• Discovery and validation of graft-versus-host disease biomarkers

  Sophie Paczesny

  173
  Citations

• Plasma biomarkers of lower gastrointestinal and liver acute GVHD.

  Andrew C. Harris;James L.M. Ferrara;Thomas M. Braun;Ernst Holler

  170
  Citations

• ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease

  Jilu Zhang;Abdulraouf M. Ramadan;Brad Griesenauer;Wei Li

  168
  Citations

• Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34+ progenitor-derived dendritic cells

  Joseph W. Fay;A. Karolina Palucka;Sophie Paczesny;Madhav Dhodapkar;Madhav Dhodapkar

  157
  Citations

• Expansion of Melanoma-specific Cytolytic CD8+ T Cell Precursors in Patients with Metastatic Melanoma Vaccinated with CD34+ Progenitor-derived Dendritic Cells

  Sophie Paczesny;Jacques Banchereau;Knut M. Wittkowski;Giovanna Saracino

  150
  Citations

• Biomarker Panel for Chronic Graft-Versus-Host Disease.

  Jeffrey Yu;Barry E. Storer;Barry E. Storer;Kushi Kushekhar;Mohammad Abu Zaid

  150
  Citations